These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32265709)

  • 1. A
    Wang H; Peng X; Ge Y; Zhang S; Wang Z; Fan Y; Huang W; Qiu M; Ye RD
    Front Pharmacol; 2020; 11():337. PubMed ID: 32265709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.
    Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H
    Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and signaling characterization of the neutrophil FPR2 selective agonist Act-389949.
    Lind S; Sundqvist M; Holmdahl R; Dahlgren C; Forsman H; Olofsson P
    Biochem Pharmacol; 2019 Aug; 166():163-173. PubMed ID: 31085160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
    Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
    Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
    J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of formyl peptide receptor 1 and formyl peptide receptor 2 reveals shared and preserved signalling profiles.
    Pajonczyk D; Sternschulte MF; Soehnlein O; Bermudez M; Raabe CA; Rescher U
    Br J Pharmacol; 2024 Sep; ():. PubMed ID: 39294930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.
    Schepetkin IA; Kirpotina LN; Khlebnikov AI; Cheng N; Ye RD; Quinn MT
    Biochem Pharmacol; 2014 Dec; 92(4):627-41. PubMed ID: 25450672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of annexin-1 in equine leucocytes and the effects of the N-terminal annexin-1 peptide, Ac2-26, on equine neutrophil superoxide production.
    Pickles KJ; Brooks AC; Rickards KJ; Cunningham FM
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):226-33. PubMed ID: 20079938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.
    Cevik-Aras H; Kalderén C; Jenmalm Jensen A; Oprea T; Dahlgren C; Forsman H
    Biochem Pharmacol; 2012 Jun; 83(12):1655-62. PubMed ID: 22410002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Inflammation and Oxidative Stress by Formyl Peptide Receptors in Cardiovascular Disease Progression.
    Caso VM; Manzo V; Pecchillo Cimmino T; Conti V; Caso P; Esposito G; Russo V; Filippelli A; Ammendola R; Cattaneo F
    Life (Basel); 2021 Mar; 11(3):. PubMed ID: 33804219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts.
    Rossi FW; Napolitano F; Pesapane A; Mascolo M; Staibano S; Matucci-Cerinic M; Guiducci S; Ragno P; di Spigna G; Postiglione L; Marone G; Montuori N; de Paulis A
    J Immunol; 2015 Jun; 194(11):5161-73. PubMed ID: 25917089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists.
    Vergelli C; Schepetkin IA; Ciciani G; Cilibrizzi A; Crocetti L; Giovannoni MP; Guerrini G; Iacovone A; Kirpotina LN; Khlebnikov AI; Ye RD; Quinn MT
    Bioorg Med Chem; 2016 Jun; 24(11):2530-2543. PubMed ID: 27134116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2.
    Skovbakke SL; Heegaard PM; Larsen CJ; Franzyk H; Forsman H; Dahlgren C
    Biochem Pharmacol; 2015 Jan; 93(2):182-95. PubMed ID: 25462815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.
    Kirpotina LN; Schepetkin IA; Khlebnikov AI; Ruban OI; Ge Y; Ye RD; Kominsky DJ; Quinn MT
    Biochem Pharmacol; 2017 Oct; 142():120-132. PubMed ID: 28690139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists.
    Dufton N; Perretti M
    Pharmacol Ther; 2010 Aug; 127(2):175-88. PubMed ID: 20546777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of formyl peptide receptor signaling by peptide ligands.
    Bae YS; Song JY; Kim Y; He R; Ye RD; Kwak JY; Suh PG; Ryu SH
    Mol Pharmacol; 2003 Oct; 64(4):841-7. PubMed ID: 14500740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling.
    Bae YS; Lee HY; Jo EJ; Kim JI; Kang HK; Ye RD; Kwak JY; Ryu SH
    J Immunol; 2004 Jul; 173(1):607-14. PubMed ID: 15210823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA.
    Cussell PJG; Howe MS; Illingworth TA; Gomez Escalada M; Milton NGN; Paterson AWJ
    PLoS One; 2019; 14(6):e0217815. PubMed ID: 31170199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors.
    Krepel SA; Wang JM
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells.
    Heo SC; Kwon YW; Jang IH; Jeong GO; Yoon JW; Kim CD; Kwon SM; Bae YS; Kim JH
    Stem Cells; 2014 Mar; 32(3):779-90. PubMed ID: 24155208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.